Systematic review: the costs of ulcerative colitis in Western countries
…, AP Yu, EQ Wu, J Xie, PM Mulani… - Alimentary …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 31, 693–707 Summary Background Early onset and complications
such as hospitalization and surgery contribute to the economic burden of ulcerative colitis …
such as hospitalization and surgery contribute to the economic burden of ulcerative colitis …
The costs of Crohn's disease in the United States and other Western countries: a systematic review
…, LA Cabanilla, E Qiong Wu, PM Mulani… - … medical research and …, 2008 - Taylor & Francis
Objective: To conduct a critical and systematic literature review of the costs of Crohn's
disease (CD) in Western industrialized countries. Research design and methods: Studies …
disease (CD) in Western industrialized countries. Research design and methods: Studies …
Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or …
…, CM Gerrits, E Kantor, Y Bao, SR Gupta, PM Mulani - …, 2010 - Springer
The absence of head-to-head trials is a common challenge in comparative effectiveness
research and health technology assessment. Indirect cross-trial treatment comparisons are …
research and health technology assessment. Indirect cross-trial treatment comparisons are …
Adalimumab induces deep remission in patients with Crohn's disease
…, RB Thakkar, AM Robinson, N Chen, PM Mulani… - Clinical …, 2014 - Elsevier
Background & Aims Patients with moderate to severe ileocolonic Crohn's disease (CD) who
received adalimumab induction and maintenance therapy had greater rates of mucosal …
received adalimumab induction and maintenance therapy had greater rates of mucosal …
Risks of developing psychiatric disorders in pediatric patients with psoriasis
…, M Tsaneva, SR Gupta, Y Bao, PM Mulani - Journal of the American …, 2012 - Elsevier
BACKGROUND: Symptoms of psoriasis can be embarrassing and distressing, and may
increase risk of developing psychiatric disorders in young people. OBJECTIVE: We sought …
increase risk of developing psychiatric disorders in young people. OBJECTIVE: We sought …
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed …
…, AP Yu, AT Cardoso, J Chao, PM Mulani… - Alimentary …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 2010; 32: 1228–1239 Summary Background Adalimumab induces
and maintains remission in adults with Crohn's disease. Aim To evaluate safety, fistula …
and maintains remission in adults with Crohn's disease. Aim To evaluate safety, fistula …
Increased risks of developing anxiety and depression in young patients with Crohn's disease
…, EQ Wu, M Yang, J Chao, PM Mulani - Official journal of the …, 2011 - journals.lww.com
OBJECTIVES: Crohn's disease (CD) is associated with substantial psychosocial burden and
increased risks for mental health disorders. This retrospective cohort study compared the …
increased risks for mental health disorders. This retrospective cohort study compared the …
Economic burden of comorbidities in patients with psoriasis is substantial
…, EQ Wu, SR Gupta, Y Bao, PM Mulani - Journal of the …, 2011 - Wiley Online Library
Background Psoriasis is frequently associated with comorbidities. Objective To estimate the
incremental economic burden associated with comorbidities in patients with psoriasis …
incremental economic burden associated with comorbidities in patients with psoriasis …
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
…, AM Robinson, J Chao, PM Mulani… - Alimentary …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 31, 1296–1309 Summary Background In the randomized, double‐
blind, placebo‐controlled CHARM trial, adalimumab was more effective than placebo in …
blind, placebo‐controlled CHARM trial, adalimumab was more effective than placebo in …
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease
PDR Higgins, M Skup, PM Mulani, J Lin… - Clinical Gastroenterology …, 2015 - Elsevier
Background & Aims We investigated whether treatment of active inflammatory bowel
disease with biologic agents is associated with a reduced risk of venous thromboembolic …
disease with biologic agents is associated with a reduced risk of venous thromboembolic …